Incyte (INCY) Other Accumulated Expenses (2017 - 2022)

Incyte (INCY) reported Other Accumulated Expenses of $57.4 million for Q2 2022, down 2.61% on a YoY basis from $58.9 million in Q2 2021, and down 22.74% quarter-over-quarter from $74.3 million in Q1 2022.

Incyte (INCY) Other Accumulated Expenses (2017 - 2022) Analysis & Trends

Incyte has reported Other Accumulated Expenses for 6 years, with the latest figure at $57.4 million in Q2 2022.

  • For the quarter ending Q2 2022, Other Accumulated Expenses fell 2.61% year-over-year to $57.4 million; the trailing twelve-month figure through Jun 2022 stood at $57.4 million (down 2.61% YoY), and the FY2021 full-year result was $45.8 million, up 30.31% from the prior year.
  • Other Accumulated Expenses for Q2 2022 stood at $57.4 million, down from $74.3 million in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $76.7 million in Q1 2021, with the low at $34.6 million in Q4 2018.
  • Historically, Other Accumulated Expenses has averaged $54.9 million across 5 years, with a median of $53.5 million in 2020.
  • Annual changes were most pronounced in 2020 — Other Accumulated Expenses surged 51.81% — and 2021, when it dropped 18.1%.
  • Incyte's Other Accumulated Expenses stood at $34.6 million in 2018, then gained by 21.64% to $42.0 million in 2019, then decreased by 16.5% to $35.1 million in 2020, then jumped by 30.31% to $45.8 million in 2021, then increased by 25.44% to $57.4 million in 2022.
  • The last three Other Accumulated Expenses figures came in at $57.4 million (Q2 2022), $74.3 million (Q1 2022), and $45.8 million (Q4 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Incyte 19.62 Bn 15.60 Bn 1.17 Bn

Historic Data

Download Data
DateValue
Jun 30, 2022 57.40 Mn
Mar 31, 2022 74.29 Mn
Dec 31, 2021 45.75 Mn
Sep 30, 2021 74.65 Mn
Jun 30, 2021 58.94 Mn
Mar 31, 2021 76.68 Mn
Dec 31, 2020 35.11 Mn
Sep 30, 2020 49.56 Mn
Jun 30, 2020 71.96 Mn
Mar 31, 2020 60.41 Mn
Dec 31, 2019 42.05 Mn
Jun 30, 2019 47.40 Mn
Mar 31, 2019 39.91 Mn
Dec 31, 2018 34.57 Mn
Dec 31, 2017 22.81 Mn